UnitedHealth Group (UNH) to Release Quarterly Earnings on Thursday

UnitedHealth Group (NYSE:UNH) is anticipated to post its quarterly earnings results before the market opens on Thursday, April 17th. Analysts expect UnitedHealth Group to post earnings of $7.24 per share and revenue of $111.56 billion for the quarter. UnitedHealth Group has set its FY25 guidance at $29.50-30.00 EPS.Persons interested in listening to the company’s earnings conference call can do so using this link.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.83 EPS. On average, analysts expect UnitedHealth Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $580.16 on Thursday. The company has a 50 day moving average of $510.86 and a 200 day moving average of $541.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market cap of $530.68 billion, a P/E ratio of 37.43, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.45%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on UNH shares. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Mizuho lifted their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Twenty-one equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $630.35.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On UnitedHealth Group

An institutional investor recently raised its position in UnitedHealth Group stock. Brighton Jones LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 176.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 44,249 shares of the healthcare conglomerate’s stock after acquiring an additional 28,231 shares during the quarter. UnitedHealth Group accounts for 0.6% of Brighton Jones LLC’s portfolio, making the stock its 24th biggest holding. Brighton Jones LLC’s holdings in UnitedHealth Group were worth $22,384,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.